HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rie Onodera Selected Research

Intracranial Hemorrhages (Intracranial Hemorrhage)

10/2017Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rie Onodera Research Topics

Disease

10Stroke (Strokes)
07/2022 - 06/2011
4Spinal Cord Injuries (Spinal Cord Injury)
07/2022 - 01/2008
4Cerebral Infarction
02/2019 - 02/2013
4Chronic Limb-Threatening Ischemia
02/2010 - 08/2007
3Neutropenia
12/2023 - 11/2017
3Ischemic Stroke
07/2022 - 10/2017
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
02/2019 - 10/2017
3Ischemia
02/2010 - 11/2008
3Thromboangiitis Obliterans (Buerger's Disease)
02/2010 - 11/2008
2Disease Progression
01/2021 - 01/2021
2Brain Ischemia (Cerebral Ischemia)
11/2016 - 05/2012
2Pain (Aches)
11/2009 - 11/2008
2Ulcer
11/2009 - 11/2008
2Peripheral Arterial Disease
11/2009 - 11/2008
1Transfusion-Related Acute Lung Injury
12/2023
1Chronic Brain Injury
07/2022
1Embolic Stroke
07/2022
1Atrial Fibrillation
07/2022
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2021
1Hyperplasia
10/2019
1Pathologic Constriction (Stenosis)
10/2019
1Brain Stem Infarctions (Weber Syndrome)
10/2018
1Demyelinating Diseases (Demyelinating Disease)
01/2018
1Intracranial Hemorrhages (Intracranial Hemorrhage)
10/2017
1Fibrosis (Cirrhosis)
02/2014
1Inflammation (Inflammations)
02/2014
1Adenoma (Adenomas)
02/2014
1Immunoglobulin G4-Related Disease
02/2014
1Phlebitis
02/2014
1Infarction (Infarctions)
06/2011
1Sensorineural Hearing Loss
11/2010
1Arteriosclerosis Obliterans
02/2010
1Connective Tissue Diseases (Connective Tissue Disease)
02/2010
1Gangrene
02/2010
1Chronic Granulomatous Disease
12/2009

Drug/Important Bio-Agent (IBA)

3AntibodiesIBA
12/2023 - 11/2017
3AntigensIBA
12/2023 - 11/2017
3Therapeutic UsesIBA
01/2021 - 05/2012
2Nerve Growth Factors (Neurotrophins)IBA
01/2021 - 01/2018
2GelatinIBA
11/2010 - 08/2007
2HydrogelsIBA
11/2010 - 08/2007
2Troleandomycin (TAO)FDA Link
02/2010 - 11/2008
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
02/2010 - 11/2009
2Pain-FreeIBA
11/2009 - 11/2008
2Oxygen (Dioxygen)IBA
11/2009 - 11/2008
1DabigatranFDA Link
07/2022
1RivaroxabanIBA
07/2022
1apixabanIBA
07/2022
1AnticoagulantsIBA
07/2022
1ThrombinFDA Link
07/2022
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
07/2022
1Factor Xa (Coagulation Factor Xa)IBA
07/2022
1NeurturinIBA
01/2021
1Brain-Derived Neurotrophic Factor (BDNF)IBA
02/2019
1Tissue Plasminogen Activator (Alteplase)FDA Link
10/2017
1Immunoglobulin G (IgG)IBA
02/2014
1Neuroprotective AgentsIBA
05/2012
1GlucocorticoidsIBA
11/2010
1Insulin-Like PeptidesIBA
11/2010
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
08/2007

Therapy/Procedure

11Intravenous Infusions
07/2022 - 02/2013
6Therapeutics
07/2022 - 11/2008
5Transplantation
02/2013 - 01/2008
2Surgical Amputation (Amputations)
02/2010 - 11/2008
2Cell Transplantation
11/2009 - 11/2008
2Cell- and Tissue-Based Therapy (Cell Therapy)
11/2009 - 11/2008
1Secondary Prevention
07/2022
1Stents
10/2019
1Intravenous Administration
06/2011
1Limb Salvage
02/2010
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
12/2009
1Intramuscular Injections
11/2008